Inflammation in Drug Discovery & Development

Venue: Wyndham Emerald Plaza

Location: San Diego, California, United States

Event Date/Time: Feb 20, 2003 End Date/Time: Feb 21, 2003
Report as Spam

Description

ORGANIZED INTO FOUR SECTIONS:

1) NOVEL ANTI-TNF PROTEINS & SMALL MOLECULE INHIBITORS

2) ADVANCES IN IL-1, GAMMA INTERFERON & IL-2 BIOLOGICS

3) NOVEL B CELL, T CELL & RECEPTOR MODULATORS

4) ADDITIONAL APPROACHES FOR NOVEL ANTI-INFLAMMATORY DRUGS



HIGHLIGHTS INCLUDE:

Discovery of Orally Active TNF Convertase Inhibitors as Anti-Rheumatoid Arthritis Drugs
AMGEN

Challenges in the Discovery and Development of Novel Chemokine Antagonists
MILLENNIUM PHARMACEUTICALS

Discovery of Novel LFA-1 Antagonists
BOEHRINGER INGELHEIM PHARMACEUTICALS

Rituxan®/MabThera® as a Novel Antirheumatic Therapy
ROCHE BIOSCIENCE

Kinase Inhibitors
RW JOHNSON, CELGENE & BRISTOL-MYERS SQUIBB

Venue

Restrictions